Reckitt Benckiser faces split trial in 2015 over Gaviscon damages
Two UK damages actions against Reckitt Benckiser for delaying the entrance of cheaper versions of popular heartburn drug Gaviscon will be tried in two phases, with dates tentatively set for early...To view the full article, register now.
Already a subscriber? Click here to view full article